CLSA Advocates for Biomedical Innovation on Capitol Hill at the BIO Fly-In

April 20, 2018
By Adam Lotspike

This month, CLSA’s Washington, D.C.-based Federal Government Relations team participated in the annual BIO Fly-In to advocate for biomedical innovation, investment, and job creation in California. CLSA took part in a total of 18 meetings with bipartisan legislators on Capitol Hill, and had the privilege of presenting 7 members of our congressional delegation with 2018 BIO “Innovator in Biotechnology” awards, for their leadership in supporting biotech innovation. This year’s award winners included California Reps. Tony Cárdenas (D-San Fernando Valley), Jim Costa (D-Fresno/Merced), Anna G. Eshoo (D-Silicon Valley), Jimmy Panetta (D-Monterey), Scott Peters (D-San Diego), David Valadao (R-Hanford), and Mimi Walters (R-Irvine).

CLSA, along with representatives from executives of California innovator companies and other California regional life sciences associations, also met with Reps. Judy Chu (D-Pasadena), and Jimmy Gomez (D-Los Angeles), as well as staff members from the offices of Majority Leader Kevin McCarthy (R-Bakersfield), Democratic Leader Nancy Pelosi (D-San Francisco), and Reps. Doris Matsui (D-Sacramento), Devin Nunes (R-Clovis), Raul Ruiz, MD (D-Palm Desert), Linda Sanchez (D-Cerritos), Mike Thompson (D-Napa), and Sens. Dianne Feinstein (D) and Kamala Harris (D).

Discussions were focused around the importance of supporting basic research and workforce development, encouraging biomedical innovation as a means for combatting the opioid crisis, encouraging renewal of the Pandemic and All-Hazards Preparedness Act (PAHPA) and proper funding of biodefense and pandemic preparedness priorities, and improving coverage and payment policies to encourage and reward innovation and value.

View more photos here. Questions? Please contact Jenny Nieto Carey, CLSA’s Vice President of Federal Government Relations & Alliance Development (